A California-based biotech company stirred things up on Wednesday after it was announced the publication of preclinical data on its lead clinical compound, LB-100.

To read the full story on AllPennyStocks.com, click here.

Lixte Biotechnology (NASDAQ:LIXT)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Lixte Biotechnology Charts.
Lixte Biotechnology (NASDAQ:LIXT)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Lixte Biotechnology Charts.